Argent Biopharma Limited has released a press release.
Medical Cannabis Clinical Study Commencing
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Panax Acquisition Completed
- Commencement of Dermatological Clinical Trials
- European CPNP Approval Granted for Derma Products
- MXC Operations Update
- New Panax Acquisition Agreement Signed, Settlement Imminent
Later from Argent Biopharma
- Cannabinoid Extraction Facility On Target Q2 Production
- Australian Legislation Changes Fast Track MXC
- Placement of $10m Closed Significantly Oversubscribed
- European API Extraction Facility Completed
- Successful MXC First Cannabinoid Production
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma